Toll Free: 1-888-928-9744
Published: Apr, 2017 | Pages:
144 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In the last several years, United States market of radiopharmaceuticals developed smoothly, with an average growth rate of 7.6%. In 2016, United States revenue of radiopharmaceuticals is nearly 1.7 billion USD. In the future, United States market is expected to witness significant growth on account of rising cancer and cancer patients, so in the next few years, radiopharmaceuticals revenue will show a trend of steady growth. In 2022 the revenue of radiopharmaceuticals is estimated to be 2.4 billion USD. The major players in United States Radiopharmaceuticals market include • Bayer • Triad Isotopes • Lantheus • GE Healthcare • Mallinckrodt • Eli Lilly • Bracco Imaging • SIEMENS • Navidea • Nordion • IBA Group • Jubilant Pharma On the basis of product, the Radiopharmaceuticals market is primarily split into • Diagnostic Radioisotopes • Therapeutic Radioisotopes On the basis on the applications, this report covers • Oncology • Cardiology • Other
Table of Contents 1 Industry Overview 1 1.1 Definition and Specifications of Radiopharmaceuticals 1 1.1.1 Definition of Radiopharmaceuticals 1 1.1.2 Specifications of Radiopharmaceuticals 1 1.2 Classification of Radiopharmaceuticals 3 1.2.1 Diagnostic Radioisotopes 4 1.2.2 Therapeutic Radioisotopes 5 1.3 Applications of Radiopharmaceuticals 5 1.3.1 Oncology 7 1.3.2 Cardiology 7 1.3.3 Other 8 1.4 Industry Chain Structure of Radiopharmaceuticals 9 1.5 Industry Regional Overview of Radiopharmaceuticals 10 1.6 Industry Policy Analysis of Radiopharmaceuticals 11 1.7 Industry News Analysis of Radiopharmaceuticals 12 2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals 15 2.1 Raw Material and Suppliers 15 2.2 Equipment Suppliers Analysis of Radiopharmaceuticals 15 2.3 Labor Cost Analysis of Radiopharmaceuticals 16 2.4 Other Costs Analysis 18 2.4.1 USA Cost of Electricity Analysis 18 2.4.2 USA Water Cost Analysis 18 2.5 Manufacturing Cost Structure Analysis of Radiopharmaceuticals 19 2.6 Manufacturing Process Analysis of Radiopharmaceuticals 20 2.7 United States Price, Cost and Gross of Radiopharmaceuticals 2012-2017 21 3 Technical Data and Manufacturing Plants Analysis of Radiopharmaceuticals 23 3.1 Capacity and Established Date of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23 3.2 Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23 3.3 R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 24 4 Production Analysis of Radiopharmaceuticals by Regions, Technology, and Applications 25 4.1 United States Production of Radiopharmaceuticals by Regions 2012-2017 25 4.2 United States Production of Radiopharmaceuticals by Product Types 2012-2017 29 4.3 United States Sales of Radiopharmaceuticals by Applications 2012-2017 32 4.4 Price Analysis of United States Radiopharmaceuticals Key Manufacturers in 2016 36 4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Radiopharmaceuticals 2012-2017 36 5 Consumption Volume and Consumption Value Analysis of Radiopharmaceuticals by Regions 38 5.1 United States Consumption Volume of Radiopharmaceuticals by Regions 2012-2017 38 5.2 United States Consumption Value of Radiopharmaceuticals by Regions 2012-2017 42 5.3 United States Consumption Price Analysis of Radiopharmaceuticals by Regions 2012-2017 46 6 Analysis of Radiopharmaceuticals Production, Supply, Sales and Market Status 2012-2017 47 6.1 Capacity, Production, Sales, and Revenue of Radiopharmaceuticals 2012-2017 47 6.2 Production Market Share and Sales Market Share of Radiopharmaceuticals 2012-2017 53 6.3 Sales Overview of Radiopharmaceuticals 2012-2017 60 6.4 Supply, Consumption and Gap of Radiopharmaceuticals 2012-2017 61 6.5 Import, Export and Consumption of Radiopharmaceuticals 2012-2017 62 6.6 Cost, Price, Revenue and Gross Margin of Radiopharmaceuticals 2012-2017 62 7 Major Manufacturers Analysis of Radiopharmaceuticals 64 7.1 Bayer 64 7.1.1 Company Profile 64 7.1.2 Product Information 65 7.1.3 Production, Price, Cost, Gross, and Revenue 65 7.2 Triad Isotopes 67 7.2.1 Company Profile 67 7.2.2 Product Information 68 7.2.3 Production, Price, Cost, Gross, and Revenue 68 7.3 Lantheus Medical Imaging 70 7.3.1 Company Profile 70 7.3.2 Product Information 71 7.3.3 Production, Price, Cost, Gross, and Revenue 71 7.4 GE Healthcare 73 7.4.1 Company Profile 73 7.4.2 Product Information 74 7.4.3 Production, Price, Cost, Gross, and Revenue 74 7.5 Mallinckrodt 76 7.5.1 Company Profile 76 7.5.2 Product Information 77 7.5.3 Production, Price, Cost, Gross, and Revenue 77 7.6 Eli Lilly 79 7.6.1 Company Profile 79 7.6.2 Product Information 80 7.6.3 Production, Price, Cost, Gross, and Revenue 80 7.7 Bracco Imaging 82 7.7.1 Company Profile 82 7.7.2 Product Information 83 7.7.3 Production, Price, Cost, Gross, and Revenue 84 7.8 SIEMENS 85 7.8.1 Company Profile 85 7.8.2 Product Information 87 7.8.3 Production, Price, Cost, Gross, and Revenue 87 7.9 Navidea 89 7.9.1 Company Profile 89 7.9.2 Product Information 90 7.9.3 Production, Price, Cost, Gross, and Revenue 90 7.10 Nordion 92 7.10.1 Company Profile 92 7.10.2 Product Information 93 7.10.3 Sales and Market Share 93 7.11 IBA Group 94 7.11.1 Company Profile 94 7.11.2 Product Information 95 7.11.3 Sales and Market Share 96 7.12 Jubilant Pharma 97 7.12.1 Company Profile 97 7.12.2 Product Information 98 7.12.3 Sales and Market Share 99 8 Price and Gross Margin Analysis 101 8.1 Analysis of Price 101 8.2 Gross Margin Analysis 101 8.3 Sales Price Comparison by Regions 102 8.4 Price Analysis of Different Radiopharmaceuticals Product Types 102 8.5 Gross Margin Analysis of Different Radiopharmaceuticals Applications 103 9 Marketing Trader or Distributor Analysis of Radiopharmaceuticals 104 9.1 Marketing Channels Status of Radiopharmaceuticals 104 9.2 Traders or Distributors of Radiopharmaceuticals with Contact Information 105 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Radiopharmaceuticals 106 9.4 United States Import, Export Analysis of Radiopharmaceuticals 106 10 Development Trend of Radiopharmaceuticals Industry 2017-2022 107 10.1 Capacity and Production Overview of Radiopharmaceuticals 2017-2022 107 10.2 Production Market Share by Product Types of Radiopharmaceuticals 2017-2022 108 10.3 Sales and Sales Revenue Overview of Radiopharmaceuticals 2017-2022 111 10.4 United States Sales of Radiopharmaceuticals by Applications 2017-2022 112 10.5 Import, Export and Consumption of Radiopharmaceuticals 2017-2022 113 10.6 Cost, Price, Revenue and Gross Margin of Radiopharmaceuticals 2017-2022 114 11 Industry Chain Suppliers of Radiopharmaceutical with Contact Information 115 11.1 Major Raw Materials Suppliers of Radiopharmaceutical with Contact Information 115 11.2 Manufacturing Equipment Suppliers of Radiopharmaceutical with Contact Information 116 11.3 Major Suppliers of Radiopharmaceuticals with Contact Information 116 11.4 Key Consumers of Radiopharmaceuticals with Contact Information 118 11.5 Supply Chain Relationship Analysis of Radiopharmaceutical 119 12 New Project Investment Feasibility Analysis of Radiopharmaceuticals 120 12.1 New Project SWOT Analysis of Radiopharmaceuticals 120 12.2 New Project Investment Feasibility Analysis of Radiopharmaceuticals 120 12.2.1 Project Name 120 12.2.2 Investment Budget 121 12.2.3 Project Product Solutions 121 12.2.4 Project Schedule 121 13 Conclusion of the United States Radiopharmaceutical Industry 2017 Market Research Report 123 14 Appendix 124 14.1 Methodology/Research Approach 124 14.1.1 Research Programs/Design 124 14.1.2 Market Size Estimation 125 14.1.3 Market Breakdown and Data Triangulation 126 14.2 Data Source 127 14.2.1 Secondary Sources 127 14.2.2 Primary Sources 128 14.3 Disclaimer 129 14.4 Author List 130 Tables and Figures Figure Picture of Radiopharmaceuticals 1 Table Specifications of Radiopharmaceuticals 1 Table Specifications of Technetium-99m 2 Table Classification of Radiopharmaceuticals 3 Figure United States Production Market Share of Radiopharmaceuticals by Type in 2016 4 Figure Diagnostic Radioisotopes Picture 4 Table Diagnostic Nuclear Medicine / Radiopharmaceuticals Types 5 Figure Therapeutic Radioisotopes Picture 5 Table Application Fields of Radiopharmaceuticals Products 5 Figure 2016 United States Radiopharmaceuticals Major Applications Sales Share 6 Figure Oncology Examples 7 Figure Cardiology Examples 7 Figure Other Examples 8 Figure Industry Chain Structure of Radiopharmaceuticals 9 Figure United States Production Market Share of Radiopharmaceuticals by Region in 2016 10 Figure United States Sales Market Share of Radiopharmaceuticals by Region in 2016 11 Table FDA-approved Radiopharmaceuticals 11 Table Industry News List of Radiopharmaceuticals 12 Table Production Base and Market Concentration Rate of Raw Material 15 Table Equipment Suppliers Analysis of Radiopharmaceuticals 15 Figure USA Labor Cost Analysis 16 Figure Cost of Employing a Factory Worker 17 Table Average Price of Electricity to Ultimate Customers 2007-2016 18 Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2016 19 Figure Manufacturing Process Analysis of Radiopharmaceuticals 20 Figure United States Price Analysis of Radiopharmaceuticals 2012-2017 (USD/Dose) 21 Figure United States Cost Analysis of Radiopharmaceuticals 2012-2017 (USD/Dose) 21 Figure United States Gross Analysis of Radiopharmaceuticals 2012-2017 22 Table Capacity (M Doses) and Established Date of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23 Table Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23 Table R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 24 Table United States Production of Radiopharmaceuticals by Regions 2012-2017 (M Doses) 25 Table United States Production Market Share of Radiopharmaceuticals by Regions 2012-2017 25 Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2012 26 Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2013 26 Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2014 27 Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2015 27 Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2016 28 Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2017 28 Table United States Production of Radiopharmaceuticals by Product Types in 2012-2017 (M Doses) 29 Table United States Production Market Share of Radiopharmaceuticals by Product Types in 2012-2017 29 Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2012 29 Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2013 30 Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2014 30 Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2015 31 Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2016 31 Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2017 32 Table United States Sales of Radiopharmaceuticals by Applications 2012-2017 (M Doses) 32 Table United States Production Market Share of Radiopharmaceuticals by Applications 2012-2017 32 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2012 33 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2013 33 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2014 34 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2015 34 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2016 35 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2017 35 Figure Price Comparison of United States Radiopharmaceuticals Key Manufacturers in 2016 (USD/Dose) 36 Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue of Radiopharmaceuticals 2012-2017 36 Table United States Consumption Volume of Radiopharmaceuticals by Regions 2012-2017 (M Doses) 38 Table United States Consumption Volume Market Share of Radiopharmaceuticals by Regions 2012-2017 38 Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2012 39 Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2013 39 Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2014 40 Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2015 40 Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2016 41 Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2017 41 Table United States Consumption Value of Radiopharmaceuticals by Regions 2012-2017 (M USD) 42 Table United States Consumption Value Market Share of Radiopharmaceuticals by Regions 2012-2017 42 Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2012 43 Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2013 43 Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2014 44 Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2015 44 Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2016 45 Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2017 45 Table Consumption Price of Radiopharmaceuticals by Regions 2012-2017 (USD/Dose) 46 Table United States and Major Manufacturers Capacity of Radiopharmaceuticals 2012-2017 (M Doses) 47 Table United States Capacity Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 47 Table United States and Major Manufacturers Production of Radiopharmaceuticals 2012-2017 (M Doses) 48 Table United States Production Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 48 Table United States and Major Manufacturers Sales of Radiopharmaceuticals 2012-2017 (M Doses) 49 Table United States Sales Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 49 Table United States and Major Manufacturers Revenue of Radiopharmaceuticals 2012-2017 (M USD) 50 Table United States Revenue Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 50 Figure United States Capacity (M Doses), Production (M Doses) and Growth Rate of Radiopharmaceuticals 2012-2017 51 Figure United States Capacity Utilization Rate of Radiopharmaceuticals 2012-2017 51 Figure United States Sales Revenue (M USD) and Growth Rate of Radiopharmaceuticals 2012-2017 52 Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2012 53 Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2013 54 Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2014 54 Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2015 55 Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2016 55 Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2017 56 Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2012 56 Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2013 57 Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2014 57 Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2015 58 Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2016 58 Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2017 59 Figure United States Sales (M Doses) and Growth Rate of Radiopharmaceuticals 2012-2017 60 Table United States and Major Manufacturers Export of Radiopharmaceuticals 2012-2017 (M Doses) 61 Table United States Supply, Consumption and Gap of Radiopharmaceuticals 2012-2017 (M Doses) 61 Table United States Import, Export and Consumption of Radiopharmaceuticals 2012-2017 (M Doses) 62 Table Price of United States Radiopharmaceuticals Major Manufacturers 2012-2017 (USD/Dose) 62 Table Gross Margin of United States Radiopharmaceuticals Major Manufacturers 2012-2017 62 Table United States and Major Manufacturers Revenue of Radiopharmaceuticals 2012-2017 (M USD) 63 Table United States Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Radiopharmaceuticals 2012-2017 63 Table Bayer Company Profile 64 Figure Radiopharmaceuticals Product Picture of Bayer 65 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer (2012-2017) 65 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 66 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 66 Table Triad Isotopes Company Profile 67 Figure Radiopharmaceuticals Product Picture of Triad Isotopes 68 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Triad Isotopes (2012-2017) 68 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 69 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 69 Table Lantheus Medical Imaging Company Profile 70 Figure Radiopharmaceuticals Product Picture of Lantheus Medical Imaging 71 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Lantheus Medical Imaging (2012-2017) 71 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 72 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 72 Table GE Healthcare Company Profile 73 Figure Radiopharmaceuticals Product Picture of GE Healthcare 74 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GE Healthcare (2012-2017) 74 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 75 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 75 Table Mallinckrodt Company Profile 76 Figure Radiopharmaceuticals Product Picture of Mallinckrodt 77 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mallinckrodt (2012-2017) 77 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 78 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 78 Table Eli Lilly Company Profile 79 Figure Radiopharmaceuticals Product Picture of Eli Lilly 80 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly (2012-2017) 80 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 81 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 81 Table Bracco Imaging Company Profile 82 Figure Radiopharmaceuticals Product Picture of Bracco Imaging 83 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bracco Imaging (2012-2017) 84 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 84 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 85 Table SIEMENS Company Profile 85 Figure Radiopharmaceuticals Product Picture of SIEMENS 87 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of SIEMENS (2012-2017) 87 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 88 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 88 Table Navidea Company Profile 89 Figure Radiopharmaceuticals Product Picture of Navidea 90 Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Navidea (2012-2017) 90 Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 91 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 91 Table Nordion Company Profile 92 Figure Radiopharmaceuticals Product Picture of Nordion 93 Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017 93 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 94 Table IBA Group Company Profile 94 Figure Radiopharmaceuticals Product Picture of IBA Group Healthcare 95 Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017 96 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 96 Table Jubilant Pharma Company Profile 97 Table Radiopharmaceuticals Product Picture of Jubilant Pharma 98 Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017 99 Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 100 Table Radiopharmaceuticals Price by Regions 2012-2017 (USD/Dose) 101 Table Radiopharmaceuticals Price by Companies 2012-2017 (USD/Dose) 101 Table Radiopharmaceuticals Gross Margin by Companies 2012-2017 101 Table Sales Price Comparison of Radiopharmaceuticals by Regions 2012-2017 (USD/Dose) 102 Table Price of Different Radiopharmaceuticals Product Types (USD/Dose) 102 Table Gross Margin of Different Radiopharmaceuticals Applications 103 Figure Marketing Channels Status of Radiopharmaceuticals 104 Table Traders or Distributors of Radiopharmaceuticals with Contact Information 105 Figure Ex-work Price, Channel Price and End Buyer Price of Radiopharmaceuticals (USD/Dose) in 2016 106 Table United States Import, Export of Radiopharmaceuticals (M Doses) 2012-2017 106 Figure United States Capacity (M Doses), Production (M Doses) and Growth Rate of Radiopharmaceuticals 2017-2022 107 Figure United States Capacity Utilization Rate of Radiopharmaceuticals 2017-2022 108 Table United States Radiopharmaceuticals Production by Product Types 2017-2022 (M Doses) 108 Table United States Radiopharmaceuticals Production Market Share by Product Types 2017-2022 108 Figure United States Production Market Share of Radiopharmaceuticals by Type in 2017 109 Figure United States Production Market Share of Radiopharmaceuticals by Type in 2022 110 Figure United States Sales (M Doses) and Growth Rate of Radiopharmaceuticals 2017-2022 111 Figure United States Sales Revenue (Million USD) and Growth Rate of Radiopharmaceuticals 2017-2022 111 Figure United States Sales of Radiopharmaceuticals by Applications 2017-2022 (M Doses) 112 Table United States Production Market Share of Radiopharmaceuticals by Applications 2017-2022 112 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2017 112 Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2022 113 Table United States Production, Import, Export and Consumption of Radiopharmaceuticals 2017-2022 (M Doses) 113 Table United States Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Radiopharmaceuticals 2017-2022 114 Table Major Raw Materials Suppliers Analysis of Radiopharmaceuticals 115 Table Equipment Suppliers Analysis of Radiopharmaceuticals 116 Table Major Suppliers of Radiopharmaceuticals with Contact Information 116 Table Key Consumers of Radiopharmaceuticals with Contact Information 118 Figure Radiopharmaceuticals Supply Chain Analysis 119 Table New Project SWOT Analysis of Radiopharmaceuticals 120 Table Project Appraisal and Financing 121 Table New Project Construction Period 121 Table New Project Investment Feasibility Analysis of Radiopharmaceuticals 121 Table Research Programs/Design for This Report 124 Figure Bottom-up and Top-down Approaches for This Report 126 Figure Data Triangulation 127 Table Key Data Information from Secondary Sources 128 Table Key Data Information from Primary Sources 129
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.